Matuszewska, A.; Sygacz, O.; Matuszewski, Ł.; Stec, S.; Grzegorzewski, A.; Gągała, J.
Association between Polymorphism eNOS4, tPA, Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase and the Occurrence of Legg–Calvé–Perthes Disease. J. Clin. Med. 2023, 12, 5209.
https://doi.org/10.3390/jcm12165209
AMA Style
Matuszewska A, Sygacz O, Matuszewski Ł, Stec S, Grzegorzewski A, Gągała J.
Association between Polymorphism eNOS4, tPA, Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase and the Occurrence of Legg–Calvé–Perthes Disease. Journal of Clinical Medicine. 2023; 12(16):5209.
https://doi.org/10.3390/jcm12165209
Chicago/Turabian Style
Matuszewska, Anna, Oliwer Sygacz, Łukasz Matuszewski, Szymon Stec, Andrzej Grzegorzewski, and Jacek Gągała.
2023. "Association between Polymorphism eNOS4, tPA, Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase and the Occurrence of Legg–Calvé–Perthes Disease" Journal of Clinical Medicine 12, no. 16: 5209.
https://doi.org/10.3390/jcm12165209
APA Style
Matuszewska, A., Sygacz, O., Matuszewski, Ł., Stec, S., Grzegorzewski, A., & Gągała, J.
(2023). Association between Polymorphism eNOS4, tPA, Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase and the Occurrence of Legg–Calvé–Perthes Disease. Journal of Clinical Medicine, 12(16), 5209.
https://doi.org/10.3390/jcm12165209
